SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea flag South Korea · Delayed Price · Currency is KRW
823.00
-37.00 (-4.30%)
At close: Mar 9, 2026

SCM Lifescience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
36,37938,70477,366175,143233,826586,015
Upgrade
Market Cap Growth
29.46%-49.97%-55.83%-25.10%-60.10%-
Upgrade
Enterprise Value
27,48140,48065,415170,464217,178551,155
Upgrade
Last Close Price
823.001891.003780.0010694.0814394.4636522.70
Upgrade
PS Ratio
23.5846.93111.21442.30532.321831.26
Upgrade
PB Ratio
1.492.733.787.155.249.29
Upgrade
P/TBV Ratio
1.522.873.827.245.289.34
Upgrade
EV/Sales Ratio
17.8149.0894.03430.49494.421722.33
Upgrade
Debt / Equity Ratio
0.110.490.190.240.140.11
Upgrade
Net Debt / Equity Ratio
-0.360.43-0.42-0.13-0.30-0.45
Upgrade
Net Debt / EBITDA Ratio
1.21-0.580.700.281.221.93
Upgrade
Net Debt / FCF Ratio
0.54-0.430.690.270.962.32
Upgrade
Asset Turnover
0.060.030.020.010.010.01
Upgrade
Inventory Turnover
2.381.101.531.290.850.55
Upgrade
Quick Ratio
6.340.1810.851.972.2710.85
Upgrade
Current Ratio
6.610.3511.552.202.3311.07
Upgrade
Return on Equity (ROE)
-41.87%-71.44%-106.53%-66.34%-41.82%-23.08%
Upgrade
Return on Assets (ROA)
-21.08%-29.10%-27.81%-18.06%-11.66%-17.14%
Upgrade
Return on Capital Employed (ROCE)
-31.10%-64.90%-53.60%-44.20%-26.80%-22.00%
Upgrade
Earnings Yield
-22.64%-31.98%-30.97%-13.09%-9.63%-1.64%
Upgrade
FCF Yield
-45.50%-36.50%-15.99%-6.67%-6.02%-2.11%
Upgrade
Buyback Yield / Dilution
-10.66%-25.01%-12.85%-21.21%-12.79%-101.51%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.